These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1586272)

  • 21. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS; Cucchiaro J; Pikalov A; Kroger H; Loebel A
    J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of subsyndromal symptoms in bipolar disorder.
    Marangell LB
    J Clin Psychiatry; 2004; 65 Suppl 10():24-7. PubMed ID: 15242329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis.
    Coppen A; Abou-Saleh M; Milln P; Bailey J; Wood K
    J Affect Disord; 1983 Nov; 5(4):353-62. PubMed ID: 6229567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Perlis RH; Ostacher MJ; Patel JK; Marangell LB; Zhang H; Wisniewski SR; Ketter TA; Miklowitz DJ; Otto MW; Gyulai L; Reilly-Harrington NA; Nierenberg AA; Sachs GS; Thase ME
    Am J Psychiatry; 2006 Feb; 163(2):217-24. PubMed ID: 16449474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term symptomatic status of bipolar I vs. bipolar II disorders.
    Judd LL; Schettler PJ; Akiskal HS; Maser J; Coryell W; Solomon D; Endicott J; Keller M
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):127-37. PubMed ID: 12890306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: post hoc analysis of patients treated with olanzapine or lithium.
    Houston JP; Lipkovich IA; Ahl J; Rotelli MD; Baker RW; Bowden CL
    J Psychiatr Res; 2007 Oct; 41(7):616-21. PubMed ID: 16236320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).
    Nolen WA; Weisler RH
    Bipolar Disord; 2013 Feb; 15(1):100-9. PubMed ID: 23228201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study.
    Strober M; Morrell W; Lampert C; Burroughs J
    Am J Psychiatry; 1990 Apr; 147(4):457-61. PubMed ID: 2107763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression during mania. Treatment response to lithium or divalproex.
    Swann AC; Bowden CL; Morris D; Calabrese JR; Petty F; Small J; Dilsaver SC; Davis JM
    Arch Gen Psychiatry; 1997 Jan; 54(1):37-42. PubMed ID: 9006398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study.
    Quitkin FM; Kane J; Rifkin A; Ramos-Lorenzi JR; Nayak DV
    Arch Gen Psychiatry; 1981 Aug; 38(8):902-7. PubMed ID: 6789793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
    Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
    Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosensory symptoms in bipolar disorder.
    Ali SO; Denicoff KD; Ketter TA; Smith-Jackson EE; Post RM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct; 10(4):223-31. PubMed ID: 9359118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium ratio and maintenance treatment response.
    Kocsis JH; Kantor JS; Lieberman KW; Stokes PE
    J Affect Disord; 1982 Sep; 4(3):213-8. PubMed ID: 6215440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial.
    Moreno-Alcázar A; Radua J; Landín-Romero R; Blanco L; Madre M; Reinares M; Comes M; Jiménez E; Crespo JM; Vieta E; Pérez V; Novo P; Doñate M; Cortizo R; Valiente-Gómez A; Lupo W; McKenna PJ; Pomarol-Clotet E; Amann BL
    Trials; 2017 Apr; 18(1):160. PubMed ID: 28376919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
    Kleindienst N; Severus WE; Greil W
    Int Clin Psychopharmacol; 2007 May; 22(3):125-31. PubMed ID: 17414737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients.
    De Dios C; Ezquiaga E; Agud JL; Vieta E; Soler B; García-López A
    J Affect Disord; 2012 Dec; 143(1-3):160-5. PubMed ID: 22925351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of depression among offspring at high and low familial risk of bipolar disorder.
    Diler RS; Goldstein TR; Hafeman D; Rooks BT; Sakolsky D; Goldstein BI; Monk K; Hickey MB; Axelson D; Iyengar S; Birmaher B
    Bipolar Disord; 2017 Aug; 19(5):344-352. PubMed ID: 28612977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients.
    Johnstone EC; Owens DG; Lambert MT; Crow TJ; Frith CD; Done DJ
    J Affect Disord; 1990 Dec; 20(4):225-33. PubMed ID: 2149728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.